SEARCH

SEARCH BY CITATION

References

  • 1
    Moser M, Roccella EJ. The treatment of hypertension: a remarkable success story. J Clin Hypertens. 2013;15:8891.
  • 2
    Hackam DG, Quinn RR, Ravani P, et al. The 2013 Canadian Hypertension Education Program (CHEP) recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2013;29:528542.
  • 3
    Daskalopoulou SS, Khan NA, Quinn RR, et al. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurment, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2012;28:270287.
  • 4
    Rabi DM, Daskalopoulou SS, Padwal RS, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurment, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2011;27:415433.
  • 5
    Quinn RR, Hemmelgarn BR, Padwal RS, et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I-blood pressure measurment, diagnosis and assessment of risk. Can J Cardiol. 2010;26:241248.
  • 6
    Hackam DG, Khan NA, Hemmelgarn BR, et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol. 2010;26:249258.
  • 7
    Lip GY, Felmeden DC, Dwivedi G. Antiplatelet agents and anticoagulants for hypertension. Cochrane Databse Syst Rev. 2011; CD003186.